| DOI: | 10.7249/RR763
|
| 报告号: | RR-763-CMS
|
| 报告题名: | Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report |
| 作者: | Peter J. Huckfeldt; Chris Chan; Samuel Hirshman; Aaron Kofner; Jodi L. Liu; Andrew W. Mulcahy; Ioana Popescu; Clare Stevens; Justin W. Timbie; Peter S. Hussey
|
| 出版者: | RAND Corporation
|
| 出版年: | 2015
|
| 发表日期: | 2015
|
| 总页数: | 226
|
| 国家: | 美国
|
| 语种: | 英语
|
| 英文关键词: | United States
; Bundled Payment for Health Services
; Cancer Treatment
; Medicaid
; Medicare
; Students
|
| 英文摘要: | This report describes research related to the design of a payment model for specialty oncology services for possible testing by the Center for Medicare and Medicaid Innovation at the Centers for Medicare & Medicaid Services (CMS). Cancer is a common and costly condition. Episode-based payment, which aims to create incentives for high-quality, low-cost care, has been identified as a promising alternative payment model for oncology care. Episode-based payment systems can provide flexibility to health care providers to select among the most effective and efficient treatment alternatives, including activities that are not currently reimbursed under Medicare payment policies. However, the model design also needs to ensure that high-quality care is delivered and that beneficial treatments are not withheld from patients. CMS asked MITRE and RAND to conduct analyses to inform design decisions related to an episode-based oncology model for Medicare beneficiaries undergoing chemotherapy treatment for cancer. In particular, this report focuses on analyses of Medicare claims data related to the definition of the initiation of an episode of chemotherapy, patterns of spending during and surrounding episodes of chemotherapy, and attribution of episodes of chemotherapy to physician practices. We found that the time between the primary cancer diagnosis and chemotherapy initiation varied widely across patients, ranging from one day to over seven years, with a median of 2.4 months. The average level of total monthly payments varied considerably across cancers, with the highest spending peak of $9,972 for lymphoma, and peaks of $3,109 for breast cancer and $2,135 for prostate cancer. |
| URL: | http://www.rand.org/content/dam/rand/pubs/research_reports/RR700/RR763/RAND_RR763.pdf
|
| Citation statistics: |
|
| 资源类型: | 研究报告
|
| 标识符: | http://119.78.100.158/handle/2HF3EXSE/27823
|
| Appears in Collections: | 影响、适应和脆弱性
科学计划与规划
气候减缓与适应
气候变化事实与影响
气候变化与战略
|
| File Name/ File Size |
Content Type |
Version |
Access |
License |
|
|---|
| RAND_RR763.pdf（2764KB） | 研究报告 | -- | 开放获取 | | View
Download
|
|
| Recommended Citation: | |
Peter J. Huckfeldt,Chris Chan,Samuel Hirshman,et al. Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report. 2015-01-01.
|
|
|